groupThe relationship between the clinico-pathological characteris-tics and survival in patients with a early stage cancer is shown inTable 6. This group included patients with NSCLC St I–IIIa, the inten-tion in such patients is for potential cure of cancer. Patients whowere not offered a curative treatment were still included in thisgroup (n = 65). The median survival was 16.2 (11.7–20.7) months